Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TEBU-BIO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   4.5% 4.7% 4.7% 2.2% 4.0% 2.9% 18.0% 15.1%   Credit score (0-100)   48 46 45 65 49 57 8 13   Credit rating   BBB BBB BBB BBB BBB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   655 661 1,170 1,499 1,122 1,578 0.0 0.0   EBITDA   183 133 615 1,000 332 148 0.0 0.0   EBIT   183 133 615 1,000 332 148 0.0 0.0   Pre-tax profit (PTP)   164.1 110.0 604.9 976.3 279.0 91.1 0.0 0.0   Net earnings   128.1 85.8 471.8 760.7 217.5 71.2 0.0 0.0   Pre-tax profit without non-rec. items   164 110 605 976 279 91.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   280 211 683 923 391 462 337 337   Interest-bearing liabilities   459 76.8 0.0 45.6 570 451 0.0 0.0   Balance sheet total (assets)   1,063 577 1,593 1,623 1,260 1,357 337 337   Net Debt   160 -118 -1,108 -778 137 -154 -337 -337     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   655 661 1,170 1,499 1,122 1,578 0.0 0.0   Gross profit growth   24.8% 1.0% 76.9% 28.1% -25.2% 40.7% -100.0% 0.0%   Employees   1 1 1 1 1 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,063 577 1,593 1,623 1,260 1,357 337 337   Balance sheet change%   21.5% -45.8% 176.2% 1.9% -22.4% 7.7% -75.1% 0.0%   Added value   183.0 132.5 615.1 1,000.1 332.2 147.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.9% 20.0% 52.6% 66.7% 29.6% 9.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.9% 16.2% 56.7% 62.2% 23.0% 11.3% 0.0% 0.0%   ROI %   27.6% 25.3% 116.9% 116.7% 34.4% 15.8% 0.0% 0.0%   ROE %   59.3% 35.0% 105.6% 94.7% 33.1% 16.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   26.3% 36.6% 42.9% 56.9% 31.0% 34.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   87.4% -88.9% -180.2% -77.8% 41.2% -104.6% 0.0% 0.0%   Gearing %   163.8% 36.4% 0.0% 4.9% 145.7% 97.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.2% 8.4% 26.5% 104.1% 17.3% 11.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.6 1.9 2.3 1.4 1.5 0.0 0.0   Current Ratio   1.3 1.6 1.9 2.3 1.4 1.5 0.0 0.0   Cash and cash equivalent   298.9 194.6 1,108.1 823.9 433.0 605.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   242.9 193.5 744.6 918.9 386.4 457.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   183 133 615 1,000 332 74 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   183 133 615 1,000 332 74 0 0   EBIT / employee   183 133 615 1,000 332 74 0 0   Net earnings / employee   128 86 472 761 218 36 0 0